1. Home
  2. GROY vs IAM Comparison

GROY vs IAM Comparison

Compare GROY & IAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gold Royalty Corp.

GROY

Gold Royalty Corp.

N/A

Current Price

$2.62

Market Cap

702.0M

Sector

N/A

ML Signal

N/A

IAM

Iambic Therapeutics Inc. Common Stock

N/A

Current Price

$12.88

Market Cap

683.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GROY
IAM
Founded
2020
2019
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
702.0M
683.0M
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
GROY
IAM
Price
$2.62
$12.88
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $5.03
N/A
AVG Volume (30 Days)
★ 1.1M
739.1K
Earning Date
11-04-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$111.19
N/A
Revenue Next Year
$20.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.45
$13.02
52 Week High
$5.45
$24.49

Technical Indicators

Market Signals
Indicator
GROY
IAM
Relative Strength Index (RSI) 33.64 7.28
Support Level $2.45 N/A
Resistance Level $2.72 $16.50
Average True Range (ATR) 0.11 2.34
MACD -0.01 -0.63
Stochastic Oscillator 0.00 4.21

Price Performance

Historical Comparison
GROY
IAM

About GROY Gold Royalty Corp.

Gold Royalty Corp is principally engaged in acquiring gold-focused royalties, streaming, and similar interests. It is a gold-focused royalty company offering creative financing solutions to the metals and mining industry. The Company operates in Bosnia and Herzegovina, Canada, which generates maximum revenue, the USA, Brazil, and Mexico.

About IAM Iambic Therapeutics Inc. Common Stock

Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.

Share on Social Networks: